UPDATE: Imprivata (IMPR) Tops Q2 EPS by 6c

(corrected with non-GAAP EPS) Imprivata (NYSE: IMPR) reported Q2 non-GAAP EPS of ($0.15), 6 cents better than the analyst estimate of ($0.21). Revenue for the quarter came in at $30 million versus the consensus estimate of $29.31 million.

Imprivata sees FY2015 EPS of ($0.60)-($0.54). Imprivata sees FY2015 revenue of $124-126 million.

Imprivata sees Q3 2015 EPS of ($0.22)-($0.20). Imprivata sees Q3 2015 revenue of $31-31.5 million.

“The second quarter marks the one year anniversary since our IPO, and I am very proud of our performance,” said Omar Hussain, President and CEO of Imprivata. “We have shown strong revenue growth, expanded our product platform, and completed a key acquisition. We have driven growth through both the acquisition of new customers, and strong add-on business to our existing customers. I am especially excited about the launch of our PatientSecure product, which expands our market to address frustrations faced by patients and registrars. PatientSecure will solidify our leadership as a security platform for healthcare, solving critical workflow challenges for electronic health records, communications, electronic prescribing, and patient identification.”

For earnings history and earnings-related data on Imprivata (IMPR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Movano (MOVE) Misses Q2 EPS by 195c